OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors
Thijs van Schaik, Lucia Moreno-Lama, Touraj Aligholipour Farzani, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114665-114665
Open Access | Times Cited: 8
Thijs van Schaik, Lucia Moreno-Lama, Touraj Aligholipour Farzani, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114665-114665
Open Access | Times Cited: 8
Showing 8 citing articles:
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 13
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 13
Emerging delivery strategy for oncolytic virotherapy
Jiao Zhu, Jinhu Ma, Meijuan Huang, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200809-200809
Open Access | Times Cited: 4
Jiao Zhu, Jinhu Ma, Meijuan Huang, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200809-200809
Open Access | Times Cited: 4
Biomaterial-based scaffolds for direct in situ programming of tumor-infiltrating T lymphocytes
Vaishali V. Inamdar, Shuai Hao, Sirkka B. Stephan, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 310-317
Closed Access | Times Cited: 1
Vaishali V. Inamdar, Shuai Hao, Sirkka B. Stephan, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 310-317
Closed Access | Times Cited: 1
From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies
Cinzia Cimino, Lorena Bonilla, Federica Conti, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 12, pp. 6062-6099
Closed Access
Cinzia Cimino, Lorena Bonilla, Federica Conti, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 12, pp. 6062-6099
Closed Access
Emerging approaches for T cell-stimulating platform development
Emily Ariail, N. Espinoza, A. Carson Stephenson, et al.
Cell Systems (2024) Vol. 15, Iss. 12, pp. 1198-1208
Closed Access
Emily Ariail, N. Espinoza, A. Carson Stephenson, et al.
Cell Systems (2024) Vol. 15, Iss. 12, pp. 1198-1208
Closed Access
Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
Yan Zhang, Xinyu Shi, Yifan Shen, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access
Yan Zhang, Xinyu Shi, Yifan Shen, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access
Bioprinted Human Lung Cancer-Mimics for Tissue Diagnostics Applications
Mian Wang, Wanlu Li, Regina Sanchez Flores, et al.
Tissue Engineering Part A (2023) Vol. 30, Iss. 11-12, pp. 270-279
Closed Access | Times Cited: 1
Mian Wang, Wanlu Li, Regina Sanchez Flores, et al.
Tissue Engineering Part A (2023) Vol. 30, Iss. 11-12, pp. 270-279
Closed Access | Times Cited: 1
Les virus oncolytiques : acteurs et vecteurs de protéines thérapeutiques contre les tumeurs
Ana Houel, Johann Foloppe
médecine/sciences (2023) Vol. 39, Iss. 11, pp. 845-854
Open Access
Ana Houel, Johann Foloppe
médecine/sciences (2023) Vol. 39, Iss. 11, pp. 845-854
Open Access
